绝经后宫内节育器去留的安全性研究

来源 :生殖与避孕 | 被引量 : 0次 | 上传用户:guoyinglonggyl
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
自1960年全国推广宫内节育器(IUD)至今己有千万妇女进入绝经期,绝经后IUD应予取出,但因种种因素尚有相当比例绝经后妇女并未取出IUD。作为异物的IUD长期不取是否安全?尚未报道。本研究调查了普查对象中绝经后妇女2658例,其中未取IUD者302例(IUD组)和无IUD妇女254例进行比较。通过病史询问和妇科检查结果提示:1.绝经后未取IUD者平均绝经年龄为49.73岁,明显高于对照组(48.99);子宫明显萎缩者与对照组相似;对健康情况无明显影响;患病史中IUD组明显低于对照组。2.通过276例宫腔分泌物直接涂片检查,白细胞和细菌计数与对照组相似。3.128例同时取出IUD,取器困难率于绝经<2年者为5%,≥2年者18%~35%。根据本研究结果,绝经后未取IUD者未见明显的危害性,但建议有条件取器者应在1年内取器,如绝经2年以上遇有取器困难而临床又无症状,不宜强行取器,以免造成严重创伤,可严密随访。 Since IUD promotion in 1960, there have been tens of millions of women entering menopause and post-menopausal IUDs should be taken out. However, a considerable proportion of these factors do not remove IUDs from postmenopausal women. As a foreign body IUD long-term take is not safe? Not yet reported. This study examined 2658 postmenopausal women in the census, in which 302 patients without IUD (IUD group) and 254 without IUD were compared. Through medical history and gynecological examination results suggest: 1. The average age of menopause who did not take IUD after menopause was 49.73 years old, which was significantly higher than that of the control group (48.99). The atrophy of the uterus was similar to that of the control group, but had no significant effect on the health status. In the control group. 2. Through 276 cases of uterine secretions direct smear examination, white blood cell and bacterial counts similar to the control group. 3.128 cases of simultaneous removal of IUD, difficulty in taking the device in menopause <2 years was 5%, ≥ 2 years, 18% to 35%. According to the results of this study, no post-menopausal IUD were no obvious hazard, but it is recommended that conditions should be removed within 1 year, such as menopause more than 2 years in case of difficulties with the device asymptomatic clinical and should not be forcibly Take the device, so as to avoid serious trauma, can be closely followed.
其他文献
会议
会议
会议
期刊
会议
会议
2020年11月,我国港口行业吞吐量综合指数为119.93点,环比下降2.7点,降幅为2.2%;同比增长9.6点,涨幅为8.7%.
期刊
会议
临床流行病学系列问答──31什么是费用-效果分析(cost-effectivenessanalysis)和费用一效用分析(cost-utilityanalysis)?前者分析费用消耗后产生的临床结果(如某预防方案的实施使患者数减少,医疗方案的实施所治... What is cost-effe